Detalhe da pesquisa
1.
68Ga-RM2 PET-MRI versus MRI alone for evaluation of patients with biochemical recurrence of prostate cancer: a single-centre, single-arm, phase 2/3 imaging trial.
Lancet Oncol
; 25(4): 501-508, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38423030
2.
Same-day post-therapy imaging with a new generation whole-body digital SPECT/CT in assessing treatment response to [177Lu]Lu-PSMA-617 in metastatic castration-resistant prostate cancer.
Eur J Nucl Med Mol Imaging
; 2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38635050
3.
Prostate Cancer, Version 3.2024.
J Natl Compr Canc Netw
; 22(3): 140-150, 2024 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38626801
4.
A plain language summary exploring a new treatment combination for untreated locally advanced or metastatic urothelial cancer: enfortumab vedotin plus pembrolizumab.
Future Oncol
; 20(7): 351-360, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37994649
5.
Lay healthcare worker financial toxicity intervention: a pilot financial toxicity screening and referral program.
Support Care Cancer
; 32(3): 161, 2024 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38366165
6.
Identification of Pathogenic Immune Cell Subsets Associated With Checkpoint Inhibitor-Induced Myocarditis.
Circulation
; 146(4): 316-335, 2022 07 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35762356
7.
Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 21(10): 1067-1096, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37856213
8.
Cabozantinib in combination with atezolizumab in patients with metastatic castration-resistant prostate cancer: results from an expansion cohort of a multicentre, open-label, phase 1b trial (COSMIC-021).
Lancet Oncol
; 23(7): 899-909, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35690072
9.
NCCN Guidelines® Insights: Prostate Cancer, Version 1.2023.
J Natl Compr Canc Netw
; 20(12): 1288-1298, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36509074
10.
Efficacy of Platinum Rechallenge in Metastatic Urothelial Carcinoma After Previous Platinum-Based Chemotherapy for Metastatic Disease.
Oncologist
; 26(12): 1026-1034, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34355457
11.
NCCN Guidelines Insights: Prostate Cancer, Version 1.2021.
J Natl Compr Canc Netw
; 19(2): 134-143, 2021 02 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33545689
12.
Five-Factor Prognostic Model for Survival of Post-Platinum Patients with Metastatic Urothelial Carcinoma Receiving PD-L1 Inhibitors.
J Urol
; 204(6): 1173-1179, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32552295
13.
Physician preferences for non-metastatic castration-resistant prostate cancer treatment.
BMC Urol
; 20(1): 73, 2020 Jun 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-32571276
14.
Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study.
Lancet Oncol
; 20(4): 581-590, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30827746
15.
The Impact of Cisplatin- or Non-Cisplatin-Containing Chemotherapy on Long-Term and Conditional Survival of Patients with Advanced Urinary Tract Cancer.
Oncologist
; 24(10): 1348-1355, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30936379
16.
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 17(5): 479-505, 2019 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31085757
17.
Safety and effectiveness of classical and alternative sunitinib dosing schedules for metastatic renal cell carcinoma: a meta-analysis.
Future Oncol
; 15(18): 2175-2190, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-31010323
18.
Checkpoint inhibitors in patients with metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.
Cancer
; 124(18): 3677-3683, 2018 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30307610
19.
Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial.
Lancet
; 389(10064): 67-76, 2017 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27939400
20.
Impact of the Number of Cycles of Platinum Based First Line Chemotherapy for Advanced Urothelial Carcinoma.
J Urol
; 200(6): 1207-1214, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30012366